Premarin

Well-established VMS efficacy

PREMARIN significantly reduced the frequency of moderate to severe hot flashes due to menopause vs placebo at 12 weeks1,2
 
All endpoints were statistically significant vs placebo, P<0.001.
Estrogens with or without progestins should be prescribed at the lowest effective dose and for the shortest duration consistent with treatment goals and risks for the individual woman.
*SD, standard deviation.